BYND
Q4/FY2025 Earnings: 8 Signals Worsened, NASDAQ Deficiency, Tail Risk Now EXISTENTIAL
Q4 revenue $61.6M (-19.7%), gross margin collapsed to 2.3%, cash burn accelerated 47% to $144.9M. NASDAQ deficiency notice received March 4. Second material weakness discovered, 10-K delayed. McDonald's EU declined 31.8%. ACCOUNTING_INTEGRITY upgraded to ALARMING, NARRATIVE_REALITY_GAP to INVERTED, EXPECTATIONS_PRICED to IMPOSSIBLE, TAIL_RISK_SEVERITY to EXISTENTIAL. Enterprise-value negative ($317M cap vs $415.7M debt).
Read the full analysis"With $200-240M in post-restructuring cash, ~17 months of runway, revenue declining 13-20% YoY, and no plausible scenario achieving breakeven, is Beyond Meat's turnaround narrative a lifeline or a countdown?"
Beyond Meat is a plant-based protein company that completed a major debt restructuring in October 2025. FY2025 revenue was $275.5M (-15.6% YoY) with gross margin collapsing to 2.8%. Cash burn accelerated 47% to $144.9M. Total debt is $415.7M against $208M cash and $317M market cap -- the company is enterprise-value negative. NASDAQ issued a deficiency notice on March 4, 2026. A second material weakness was discovered, the 10-K filing is delayed, and Form S-3 eligibility has been lost. McDonald's EU -- previously the single positive finding -- declined 31.8% in Q4. Updated March 31, 2026 with Q4/FY2025 data.
Executive Summary
Cross-lens roll-up assessment
Beyond Meat exhibits severe fundamental distress across every analytical dimension examined. All 11 signals across 5 lenses converged negatively with zero Voice of Reason interventions -- a rare unanimous directional alignment indicating the evidence base is unambiguously pointing toward distress. The October 2025 debt restructuring eliminated the near-term maturity wall but created approximately 5x equity dilution, and the company's estimated 17-month cash runway provides a finite window within which no plausible scenario achieves operating cash flow breakeven. Recovery, if it occurs, would require a discontinuous event -- acquisition, major new partnership, or fundamental shift in plant-based protein demand -- for which there is no current evidentiary support.
HIGHER_SCRUTINY maintained pending 10-K filing, but reclassification to AVOID is contingent on the going concern opinion. Seven signals worsened. The company is enterprise-value negative ($317M cap vs $415.7M debt). NASDAQ cascade is live. However: (1) cash runway of ~14 months from March 2026 remains nonzero; (2) reverse split is pre-authorized and could buy compliance time; (3) 10-K filing, when it comes, is the single most important determination. If the 10-K contains a going concern qualification, reclassification to AVOID would be warranted. [Updated 2026-03-31]
Key Takeaways
- •FUNDING_FRAGILITY is CRITICAL (Stress Scanner + Roadkill Radar, E2, HIGH confidence) -- Cash burn accelerated 47% to $144.9M/year. Cash $208M vs debt $415.7M. Runway ~14 months from March 2026. NASDAQ deficiency notice received. Form S-3 eligibility lost. Unprocessed Foods facility fully drawn. Both lenses now agree on CRITICAL (prior STRAINED/CRITICAL conflict resolved). [Updated 2026-03-31]
- •CAPITAL_DEPLOYMENT is DESTRUCTIVE (Stress Scanner, E2, HIGH confidence) -- Shares outstanding 453.7M (was 383M estimated). Full $100M Ahimsa facility drawn. EU subsidiary pledged as second-lien collateral. $48.1M write-down of assets held for sale. Evidence strengthened but assessment unchanged. [Updated 2026-03-31]
- •ACCOUNTING_INTEGRITY is ALARMING (Fugazi Filter, E2, HIGH confidence) -- UPGRADED from CONCERNING. Second independent material weakness (inventory provision) on top of original (impairment assessment). 10-K filing delayed beyond statutory deadline. Errors found in previously issued interim financials. $38.9M litigation accrual (probable loss on securities fraud class action). The original Issue A/B framework no longer tenable -- Issue A alone now shows multiple independent control failures. [Updated 2026-03-31]
- •GOVERNANCE_ALIGNMENT is MISALIGNED (Fugazi Filter, E2, MEDIUM-HIGH confidence) -- EU subsidiary (Beyond Meat EU B.V.) pledged as guarantor for 2030 notes. Full $100M Ahimsa facility drawn. Zero insider purchases continues. Gap to CAPTURED narrowing but not yet there -- Ahimsa has not gained board seats. [Updated 2026-03-31]
- •OPERATIONAL_EXECUTION is FAILING (Roadkill Radar, E3, HIGH confidence) -- Q4 2025 revenue $61.6M (-19.7%). FY2025 gross margin collapsed to 2.8% (was 6.9% through 9 months). McDonald's EU declined 31.8% in Q4 -- the single positive finding is eroding. Q1 2026 guidance $57-59M implies continued decline. 3+ years of turnaround initiatives without measurable results. [Updated 2026-03-31]
- •TAIL_RISK_SEVERITY is EXISTENTIAL (Black Swan Beacon, E3, HIGH confidence) -- UPGRADED from SEVERE. NASDAQ Death Spiral Stage 1 confirmed (deficiency notice March 4). Governance capture progressing (EU pledge, full facility draw, debt exceeds market cap). 3/4 simultaneous escalation elements materialized. Compound interactions now observable as interacting feedback loops. Timeline compressed to 5-14 months. [Updated 2026-03-31]
Key Tensions
- •Funding fragility: CRITICAL/STRAINED conflict RESOLVED -- Both lenses now at CRITICAL after cash burn accelerated 47%, NASDAQ deficiency impaired capital market access, and Unprocessed Foods backstop exhausted. [Updated 2026-03-31]
- •Expectations now IMPOSSIBLE -- The sole non-operational path (brand acquisition) has been functionally closed by $415.7M debt exceeding $317M market cap, EU asset encumbrance, and NASDAQ/filing complications. [Updated 2026-03-31]
- •The distress spiral has accelerated into observable feedback loops -- Revenue decline ($275.5M, -15.6%) forces cash burn acceleration ($144.9M, +47%) forces NASDAQ non-compliance forces S-3 loss forces capital market impairment. Each step confirmed at E2-E3. [Updated 2026-03-31]
Fugazi Filter
Are the numbers trustworthy?
Dual-Axis Risk Classification
Position shows Accounting Integrity × Funding Fragility
Evidence suggests likely misrepresentation. The risk of permanent capital loss is too high regardless of potential upside.
Key FindingsClick to expand details
Signal AssessmentsClick for full context
| Signal | Scale | Assessment | Evidence |
|---|---|---|---|
Accounting Integrity | — | ALARMING | 2Corroborated |
Governance Alignment | — | MISALIGNED | 2Corroborated |
Model Debates
Cross-Lens Insights
Where Lenses Agree
- Cash burn and liquidity crisis are the existential constraint (3 lenses)
- Revenue decline is structural and accelerating (3 lenses)
- Debt restructuring bought time but created new structural problems (3 lenses)
- Management credibility has been systematically eroded (3 lenses)
- Governance structure favors related party over public equity (2 lenses)
Where Lenses Differ
FUNDING_FRAGILITY
Both lenses use identical math (17 months of runway) but disagree on whether this constitutes adequate or critical buffer for a company with no path to breakeven.
Unprocessed Foods Lending Terms
The Fugazi Filter distinguished between the defensible lending rate and the concerning warrant repricing. The Stress Scanner assessed the broader pattern without that distinction.
The following publicly available documents were collected and extracted into a structured fact dossier that powered this analysis.
SEC Filing
- Annual Report (10-K) -- FY2024
- Quarterly Report (10-Q) -- Q3 2025
- Quarterly Report (10-Q) -- Q2 2025
- Quarterly Report (10-Q) -- Q1 2025
- Quarterly Report (10-Q) -- Q3 2024
- Current Report (8-K) -- Material Weakness Disclosure (Nov 14, 2025)
- Current Report (8-K) -- Q3 2025 Earnings Release (Nov 10, 2025)
- Current Report (8-K) -- Exchange Offer (Oct 30, 2025)
- Current Report (8-K/A) -- Exchange Offer Amendment (Oct 30, 2025)
- Current Reports (8-K) -- 6 additional filings through Jan 2026
- Additional Proxy Solicitation (DEFA14A) -- Exchange Vote (Nov 2025)
- Form 4 Filings (20 filings, Nov 2025 - Jan 2026)
- Form 144 Proposed Sales (10 filings)
- Q4/FY2025 Earnings Press Release (8-K, March 31, 2026)
- NASDAQ Deficiency Notice (8-K Item 3.01, March 6, 2026)
- EU Subsidiary Guaranty -- First Supplemental Indenture (8-K, January 12, 2026)
- Preliminary Q4/FY2025 Results (8-K, March 16, 2026)
- Current Report (8-K) -- Roquette Pea Protein Supply Agreement + Employment Inducement Plan (April 2, 2026)
Earnings Transcript
- Q3 2025 Earnings Call Transcript
- Q2 2025 Earnings Call Transcript
- Q1 2025 Earnings Call Transcript
- Q4 2024 Earnings Call Transcript
- Q4 2025 / FY2025 Earnings Call Transcript (March 31, 2026)
Research Document
- Litigation History (10 cases) -- CourtListener